Anti-CEP57L1 monoclonal antibody

Pre-made anti-CEP57L1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CEP57L1/CEP57L1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2422-Ab-1/ GM-Tg-hg-IP2422-Ab-2Anti-Human CEP57L1 monoclonal antibodyHuman
GM-Tg-rg-IP2422-Ab-1/ GM-Tg-rg-IP2422-Ab-2Anti-Rat CEP57L1 monoclonal antibodyRat
GM-Tg-mg-IP2422-Ab-1/ GM-Tg-mg-IP2422-Ab-2Anti-Mouse CEP57L1 monoclonal antibodyMouse
GM-Tg-cynog-IP2422-Ab-1/ GM-Tg-cynog-IP2422-Ab-2Anti-Cynomolgus/ Rhesus macaque CEP57L1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2422-Ab-1/ GM-Tg-felg-IP2422-Ab-2Anti-Feline CEP57L1 monoclonal antibodyFeline
GM-Tg-cang-IP2422-Ab-1/ GM-Tg-cang-IP2422-Ab-2Anti-Canine CEP57L1 monoclonal antibodyCanine
GM-Tg-bovg-IP2422-Ab-1/ GM-Tg-bovg-IP2422-Ab-2Anti-Bovine CEP57L1 monoclonal antibodyBovine
GM-Tg-equg-IP2422-Ab-1/ GM-Tg-equg-IP2422-Ab-2Anti-Equine CEP57L1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2422-Ab-1/ GM-Tg-hg-IP2422-Ab-2; GM-Tg-rg-IP2422-Ab-1/ GM-Tg-rg-IP2422-Ab-2;
GM-Tg-mg-IP2422-Ab-1/ GM-Tg-mg-IP2422-Ab-2; GM-Tg-cynog-IP2422-Ab-1/ GM-Tg-cynog-IP2422-Ab-2;
GM-Tg-felg-IP2422-Ab-1/ GM-Tg-felg-IP2422-Ab-2; GM-Tg-cang-IP2422-Ab-1/ GM-Tg-cang-IP2422-Ab-2;
GM-Tg-bovg-IP2422-Ab-1/ GM-Tg-bovg-IP2422-Ab-2; GM-Tg-equg-IP2422-Ab-1/ GM-Tg-equg-IP2422-Ab-2
Products NameAnti-CEP57L1 monoclonal antibody
Formatmab
Target NameCEP57L1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CEP57L1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2422-Ag-1Recombinant multi-species CE57L/ CEP57L1/ C6orf182 protein
    ORF Viral VectorpGMLPm001486mouse Cep57l1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001486mouse Cep57l1 Lentivirus particle


    Target information

    Target IDGM-IP2422
    Target NameCEP57L1
    Gene ID285753,103268,294519,700109,475018,101082061,519522,100066609
    Gene Symbol and Synonyms2410017P07Rik,4930484D11Rik,bA487F23.2,C4H6orf182,C6orf182,CEP57L1,cep57R
    Uniprot AccessionQ8IYX8,Q6AXZ4
    Uniprot Entry NameCE57L_HUMAN,CE57L_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183137
    Target ClassificationN/A

    The target: CEP57L1, gene name: CEP57L1, also named as C6orf182, bA487F23.2, cep57R. Enables identical protein binding activity. Predicted to be located in cytoplasm and microtubule. Predicted to be active in centrosome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.